Literature DB >> 12742995

Critical role of L-arginine in endothelial cell survival during oxidative stress.

Christoph V Suschek1, Oliver Schnorr, Karsten Hemmrich, Olivier Aust, Lars-Oliver Klotz, Helmut Sies, Victoria Kolb-Bachofen.   

Abstract

BACKGROUND: Oxidative damage of vascular endothelium represents an important initiation step in the development of atherosclerosis. Recently, we reported about protection of inducible nitric oxide synthase (iNOS)-derived high-output NO in endothelial cells. Because iNOS activity critically depends on the availability of its substrate l-arginine, the present study aims at elucidating iNOS-mediated effects on H2O2-induced apoptosis of cytokine-activated rat aortic endothelial cells (AECs) subject to medium l-arginine concentrations. METHODS AND
RESULTS: In cytokine-activated AECs, iNOS activity was found to be half-maximal at 60 micromol/L arginine, which represents the medium serum level in rats but also in humans. Maximal activity is seen at and above 200 micromol/L arginine. Activated cells grown in the absence of arginine with minimal iNOS activity are highly sensitive toward H2O2-induced apoptosis, and increases in medium arginine concentrations result in increased cell survival. Moreover, competition experiments show that iNOS activity is completely dependent on cationic amino acid transporter-mediated arginine uptake. We also find that the arginine-dependent protection includes inhibition of endothelial lipid peroxidation and increases in the expression of vasoprotective stress response genes.
CONCLUSIONS: Our data demonstrate that arginine concentrations corresponding to physiological serum levels do not allow for optimal endothelial iNOS activity. Thus, decreases in systemic arginine concentrations, or locally within atherosclerotic plaques, will impair the endothelial iNOS-mediated stress response and will significantly increase the risk of endothelial dysfunction.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12742995     DOI: 10.1161/01.CIR.0000066909.13953.F1

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  12 in total

Review 1.  Recent advances in arginine metabolism: roles and regulation of the arginases.

Authors:  Sidney M Morris
Journal:  Br J Pharmacol       Date:  2009-06-05       Impact factor: 8.739

2.  Combined hyperlipidemia in patients with lysinuric protein intolerance.

Authors:  Laura M Tanner; Harri Niinikoski; Kirsti Näntö-Salonen; Olli Simell
Journal:  J Inherit Metab Dis       Date:  2010-02-23       Impact factor: 4.982

3.  L-arginine and Alzheimer's disease.

Authors:  Jing Yi; Laura L Horky; Avi L Friedlich; Ying Shi; Jack T Rogers; Xudong Huang
Journal:  Int J Clin Exp Pathol       Date:  2008-10-02

4.  Enhancing eNOS activity with simultaneous inhibition of IKKβ restores vascular function in Ins2(Akita+/-) type-1 diabetic mice.

Authors:  Manickam Krishnan; Preethi Janardhanan; Linda Roman; Robert L Reddick; Mohan Natarajan; Rien van Haperen; Samy L Habib; Rini de Crom; Sumathy Mohan
Journal:  Lab Invest       Date:  2015-07-27       Impact factor: 5.662

5.  Diminished global arginine bioavailability and increased arginine catabolism as metabolic profile of increased cardiovascular risk.

Authors:  W H Wilson Tang; Zeneng Wang; Leslie Cho; Danielle M Brennan; Stanley L Hazen
Journal:  J Am Coll Cardiol       Date:  2009-06-02       Impact factor: 24.094

6.  Direct detection of diverse metabolic changes in virally transformed and tax-expressing cells by mass spectrometry.

Authors:  Prabhakar Sripadi; Bindesh Shrestha; Rebecca L Easley; Lawrence Carpio; Kylene Kehn-Hall; Sebastien Chevalier; Renaud Mahieux; Fatah Kashanchi; Akos Vertes
Journal:  PLoS One       Date:  2010-09-07       Impact factor: 3.240

Review 7.  Arginase as a Critical Prooxidant Mediator in the Binomial Endothelial Dysfunction-Atherosclerosis.

Authors:  Luiza A Rabelo; Fernanda O Ferreira; Valéria Nunes-Souza; Lucas José Sá da Fonseca; Marília O F Goulart
Journal:  Oxid Med Cell Longev       Date:  2015-05-04       Impact factor: 6.543

8.  Arginase activity and nitric oxide levels in patients with obstructive sleep apnea syndrome.

Authors:  Meral Yüksel; Hacer Kuzu Okur; Zerrin Pelin; Ayliz Velioğlu Öğünç; Levent Öztürk
Journal:  Clinics (Sao Paulo)       Date:  2014       Impact factor: 2.365

9.  Asymmetric dimethylarginine accumulates in the kidney during ischemia/reperfusion injury.

Authors:  Yosuke Nakayama; Seiji Ueda; Sho-ichi Yamagishi; Nana Obara; Kensei Taguchi; Ryotaro Ando; Yusuke Kaida; Ryuji Iwatani; Kumiko Kaifu; Miyuki Yokoro; Maki Toyonaga; Takuo Kusumoto; Kei Fukami; Seiya Okuda
Journal:  Kidney Int       Date:  2013-10-09       Impact factor: 10.612

Review 10.  Role of Uremic Toxins for Kidney, Cardiovascular, and Bone Dysfunction.

Authors:  Hideki Fujii; Shunsuke Goto; Masafumi Fukagawa
Journal:  Toxins (Basel)       Date:  2018-05-16       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.